• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性心血管疾病

Cardiovascular disease in women.

作者信息

Castelli W P

机构信息

Department of Preventive Medicine and Epidemiology, Harvard Medical School.

出版信息

Am J Obstet Gynecol. 1988 Jun;158(6 Pt 2):1553-60, 1566-7. doi: 10.1016/0002-9378(88)90189-5.

DOI:10.1016/0002-9378(88)90189-5
PMID:3377033
Abstract

Cardiovascular disease is the leading cause of death in American women. Atherosclerotic diseases, primarily myocardial infarction and stroke, are important causes of morbidity and mortality among women. Contrary to popular belief, the actual number of myocardial infarctions in men and women is similar, although women develop cardiovascular disease an average of 10 years later than do men. Total serum cholesterol level is a major indicator of risk of coronary heart disease; for every 1% increase in the total serum cholesterol level, a 2% increase in incidence of coronary heart disease is found. A high level of low-density lipoproteins is an independent risk factor for coronary heart disease in both mean and women, but high triglyceride level is an independent risk factor only in women. Conversely, the higher the level of high-density lipoprotein, the lower the risk of coronary heart disease. To reduce the risk of coronary heart disease, target levels of total serum cholesterol must be lowered from 300 to 200 mg/dl. If the total cholesterol/high-density lipoprotein ratio is greater than or equal to 4.5 of if the low-density lipoprotein concentration is greater than 150 mg/dl, the patient is at high risk for coronary heart disease. Clinical trials that use diet or drugs to lower serum cholesterol levels have consistently shown a 2% reduction in the incidence of coronary heart disease for every 1% reduction in total serum cholesterol level.

摘要

心血管疾病是美国女性的首要死因。动脉粥样硬化疾病,主要是心肌梗死和中风,是女性发病和死亡的重要原因。与普遍看法相反,男性和女性心肌梗死的实际发生数量相似,尽管女性患心血管疾病的平均时间比男性晚10年。血清总胆固醇水平是冠心病风险的主要指标;血清总胆固醇水平每升高1%,冠心病发病率就会升高2%。高水平的低密度脂蛋白是男性和女性冠心病的独立危险因素,但高甘油三酯水平仅是女性的独立危险因素。相反,高密度脂蛋白水平越高,冠心病风险越低。为降低冠心病风险,血清总胆固醇的目标水平必须从300毫克/分升降至200毫克/分升。如果总胆固醇/高密度脂蛋白比值大于或等于4.5,或者低密度脂蛋白浓度大于150毫克/分升,患者患冠心病的风险就很高。使用饮食或药物降低血清胆固醇水平的临床试验一直表明,血清总胆固醇水平每降低1%,冠心病发病率就会降低2%。

相似文献

1
Cardiovascular disease in women.女性心血管疾病
Am J Obstet Gynecol. 1988 Jun;158(6 Pt 2):1553-60, 1566-7. doi: 10.1016/0002-9378(88)90189-5.
2
Cholesterol, lipoproteins, and coronary heart disease in women.女性体内的胆固醇、脂蛋白与冠心病
Clin Chem. 1988;34(8B):B60-70.
3
Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.基层医疗中总胆固醇水平大于5.17 mmol/L(200 mg/dL)患者的低高密度脂蛋白胆固醇及其他冠心病危险因素。CEN的一份报告
J Am Board Fam Pract. 1991 Sep-Oct;4(5):285-97.
4
Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.空军/德克萨斯冠状动脉粥样硬化预防研究(AFCAPS/TexCAPS)队列亚组筛查期间血清低密度脂蛋白胆固醇水平的不稳定性。
J Am Osteopath Assoc. 2002 Jul;102(7):377-84.
5
A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study.高危人群。弗雷明汉姆研究中高血压患者高胆固醇水平的患病率。
Am J Med. 1986 Feb 14;80(2A):23-32. doi: 10.1016/0002-9343(86)90157-9.
6
Plasma triglyceride level and mortality from coronary heart disease.血浆甘油三酯水平与冠心病死亡率
N Engl J Med. 1993 Apr 29;328(17):1220-5. doi: 10.1056/NEJM199304293281702.
7
Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease risk.胆固醇指南、脂蛋白胆固醇水平和甘油三酯水平:冠心病风险误分类的可能性。
J Lab Clin Med. 1989 Mar;113(3):325-34.
8
Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.原发性高密度脂蛋白胆固醇水平低与冠心病、心血管疾病及死亡风险:动脉粥样硬化多民族研究结果
Am J Epidemiol. 2016 May 15;183(10):875-83. doi: 10.1093/aje/kwv305. Epub 2016 Apr 18.
9
High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease.高密度脂蛋白胆固醇低血清水平作为男性冠心病患者的唯一危险因素。
Clin Ter. 1992 Aug;141(8):109-14.
10
[Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].不同低密度脂蛋白表型冠心病患者心血管危险因素的患病率
Medicina (Kaunas). 2005;41(11):925-31.

引用本文的文献

1
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase.一种强效芳香化酶和醛固酮合酶双重抑制剂的发现。
ACS Pharmacol Transl Sci. 2023 Nov 23;6(12):1870-1883. doi: 10.1021/acsptsci.3c00183. eCollection 2023 Dec 8.
2
Anthropometric indices, blood pressure, and lipid profile status among women using progestin-only contraceptives: comparative cross-sectional study.单纯孕激素避孕药使用者的人体测量指数、血压和血脂状况:比较横断面研究。
BMC Womens Health. 2021 Jan 23;21(1):34. doi: 10.1186/s12905-021-01178-8.
3
Gender differences among ischemic heart disease patients enrolled in a cardiac rehabilitation program.
参加心脏康复计划的缺血性心脏病患者中的性别差异。
Egypt Heart J. 2020 Mar 30;72(1):15. doi: 10.1186/s43044-020-00052-6.
4
Gender differences of in-hospital outcomes in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.药物洗脱支架时代接受经皮冠状动脉介入治疗患者住院结局的性别差异
Medicine (Baltimore). 2019 May;98(20):e15557. doi: 10.1097/MD.0000000000015557.
5
Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.萝卜硫素可减轻高胆固醇血症家兔动脉粥样硬化的发展并改善内皮功能障碍。
Exp Biol Med (Maywood). 2016 Feb;241(4):426-36. doi: 10.1177/1535370215609695. Epub 2015 Oct 20.
6
Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.根据性别和心血管疾病的存在情况评估 2 型糖尿病的心脏代谢控制的差异:eControl 研究的结果。
Int J Endocrinol. 2014;2014:131709. doi: 10.1155/2014/131709. Epub 2014 Sep 21.
7
Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.2型糖尿病患者心血管危险因素综合控制中的性别差异。
Diabetes Technol Ther. 2014 Jul;16(7):421-7. doi: 10.1089/dia.2013.0329. Epub 2014 Apr 15.
8
Cardiometabolic risk profiles in pre- versus postmenopausal women with spinal cord injury:: preliminary findings.脊髓损伤的绝经前与绝经后女性的心脏代谢风险概况:初步研究结果。
Top Spinal Cord Inj Rehabil. 2012 Fall;18(4):322-30. doi: 10.1310/sci1804-322.
9
Significant association of female gender with lower degree of pathological 99mTc-sestamibi scintigraphy results as well as higher cardiac-related deaths free survival in elderly patients.在老年患者中,女性性别与较低程度的病理性99mTc-司他米比闪烁扫描结果以及较高的无心脏相关死亡生存率显著相关。
Med Klin (Munich). 2010 Dec;105(12):901-9. doi: 10.1007/s00063-010-1155-y. Epub 2011 Jan 16.
10
Raising HDL cholesterol in women.提高女性的高密度脂蛋白胆固醇水平。
Int J Womens Health. 2010 Aug 9;1:181-91. doi: 10.2147/ijwh.s5110.